Suchergebnisse - "Uprety, Nadima"

PubPharm (4)

1

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors : a phase 1/2 trial

enthalten in: Nature medicine | 2024

von Marin, D. | Li, Y. | Basar, R. | +33

2

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

enthalten in: Nature medicine | 2022

von Li, Y. | Basar, R. | Wang, G. | +29

ErratumIn: Nat Med. 2024 Jan 5;:. - PMID 38182787

3

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

enthalten in: Blood | 2021

von Daher, M. | Basar, R. | Gokdemir, E. | +52

CommentIn: Blood. 2021 Feb 4;137(5):579-581. - PMID 33538803

4

GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells

enthalten in: Frontiers in immunology | 2021

von Liu, E. | Ang, S. | Kerbauy, L. | +23

1
[1]